Arbutus Biopharma Corp Stock Probability of Future Stock Price Finishing Over 5.92
Arbutus Biopharma's future price is the expected price of Arbutus Biopharma instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Arbutus Biopharma Corp performance during a given time horizon utilizing its historical volatility. Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.
Please specify Arbutus Biopharma's target price for which you would like Arbutus Biopharma odds to be computed.
Arbutus |
Arbutus Biopharma Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Arbutus Biopharma for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Arbutus Biopharma Corp can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Arbutus Biopharma is not yet fully synchronised with the market data | |
| Arbutus Biopharma generated a negative expected return over the last 90 days | |
| Arbutus Biopharma has some characteristics of a very speculative penny stock | |
| The company reported the previous year's revenue of 18.14 M. Net Loss for the year was (72.85 M) with loss before overhead, payroll, taxes, and interest of (56.05 M). | |
| Arbutus Biopharma Corp currently holds about 150.2 M in cash with (85.94 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.0. | |
| Arbutus Biopharma has a frail financial position based on the latest SEC disclosures | |
| Roughly 55.0% of the company shares are held by institutions such as insurance companies |
Arbutus Biopharma Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Arbutus Stock often depends not only on the future outlook of the current and potential Arbutus Biopharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Arbutus Biopharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 166 M | |
| Cash And Short Term Investments | 126 M |
Arbutus Biopharma Technical Analysis
Arbutus Biopharma's future price can be derived by breaking down and analyzing its technical indicators over time. Arbutus Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Arbutus Biopharma Corp. In general, you should focus on analyzing Arbutus Stock price patterns and their correlations with different microeconomic environments and drivers.
Arbutus Biopharma Predictive Forecast Models
Arbutus Biopharma's time-series forecasting models is one of many Arbutus Biopharma's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Arbutus Biopharma's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Arbutus Biopharma Corp
Checking the ongoing alerts about Arbutus Biopharma for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Arbutus Biopharma Corp help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Arbutus Biopharma is not yet fully synchronised with the market data | |
| Arbutus Biopharma generated a negative expected return over the last 90 days | |
| Arbutus Biopharma has some characteristics of a very speculative penny stock | |
| The company reported the previous year's revenue of 18.14 M. Net Loss for the year was (72.85 M) with loss before overhead, payroll, taxes, and interest of (56.05 M). | |
| Arbutus Biopharma Corp currently holds about 150.2 M in cash with (85.94 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.0. | |
| Arbutus Biopharma has a frail financial position based on the latest SEC disclosures | |
| Roughly 55.0% of the company shares are held by institutions such as insurance companies |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Tools for Arbutus Stock
When running Arbutus Biopharma's price analysis, check to measure Arbutus Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arbutus Biopharma is operating at the current time. Most of Arbutus Biopharma's value examination focuses on studying past and present price action to predict the probability of Arbutus Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arbutus Biopharma's price. Additionally, you may evaluate how the addition of Arbutus Biopharma to your portfolios can decrease your overall portfolio volatility.
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |